Baird Financial Group, Inc. Gilead Sciences, Inc. Transaction History

Baird Financial Group, Inc.

$54.4 Billion
Q2 2025

A detailed history of Baird Financial Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 170,425 shares of GILD stock, worth $20.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

170,425

Previous 178,748 4.66%

Holding current value

$20.4 Million

Previous $20 Million 5.66%

% of portfolio

0.03%

Previous 0.04%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$96.91 - $113.0 $806,581 - $940,499	-8,323 Reduced 4.66%	170,425 $18.9 Million
Q1 2025 May 15, 2025	SELL	$89.14 - $117.41 $5.46 Million - $7.2 Million	-61,294 Reduced 25.53%	178,748 $20 Million
Q4 2024 Feb 14, 2025	SELL	$83.95 - $97.9 $1.24 Million - $1.44 Million	-14,715 Reduced 5.78%	240,042 $22.2 Million
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $711,247 - $897,097	-10,681 Reduced 4.02%	254,757 $21.4 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $4.39 Million - $5.06 Million	69,495 Added 35.47%	265,438 $18.2 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $4.39 Million - $5.35 Million	-61,332 Reduced 23.84%	195,943 $14.4 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $1.86 Million - $2.11 Million	-25,350 Reduced 8.97%	257,275 $20.8 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $9.7 Million - $10.6 Million	-131,195 Reduced 31.7%	282,625 $21.2 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $10.8 Million - $12.3 Million	141,571 Added 52.0%	413,820 $31.9 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $1.58 Million - $1.8 Million	20,442 Added 8.12%	272,249 $22.6 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $300,617 - $343,382	-5,049 Reduced 1.67%	297,816 $18.4 Million
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $8.4 Million - $9.46 Million	-145,544 Reduced 32.46%	302,865 $18.7 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $963,962 - $1.21 Million	16,643 Added 3.85%	448,409 $26.7 Million
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $12.3 Million - $14 Million	-189,988 Reduced 30.56%	431,766 $31.4 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $862,573 - $930,621	-12,743 Reduced 2.01%	621,754 $43.4 Million
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $51,981 - $56,797	-819 Reduced 0.13%	634,497 $43.7 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $2.53 Million - $2.89 Million	42,229 Added 7.12%	635,316 $41.1 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $1.92 Million - $2.19 Million	-33,943 Reduced 5.41%	593,087 $34.6 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $2.68 Million - $3.36 Million	43,078 Added 7.38%	627,030 $39.6 Million
Q2 2020 Oct 22, 2020	SELL	$72.34 - $84.0 $1.53 Million - $1.77 Million	-21,125 Reduced 3.49%	583,952 $44.9 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $9.81 Million - $11.4 Million	135,589 Added 28.88%	605,077 $40.4 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $2.87 Million - $3.67 Million	-45,791 Reduced 8.89%	469,488 $35.1 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $14.8 Million - $16.3 Million	-240,273 Reduced 31.8%	515,279 $33.5 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $1.32 Million - $1.45 Million	21,047 Added 2.87%	755,552 $47.9 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $2.25 Million - $2.52 Million	-36,286 Reduced 4.71%	734,505 $49.6 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $12.6 Million - $14.1 Million	201,495 Added 35.39%	770,791 $50.1 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $7.82 Million - $10.2 Million	129,194 Added 29.36%	569,296 $35.6 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $1.7 Million - $1.88 Million	-23,794 Reduced 5.13%	440,102 $34.3 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $975,860 - $1.14 Million	-15,041 Reduced 3.14%	463,896 $32.9 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $2.73 Million - $3.33 Million	37,545 Added 8.51%	478,937 $36.1 Million
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $944,018 - $1.11 Million	-13,268 Reduced 2.92%	441,392 $31.6 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $20 Million - $23.7 Million	-277,746 Reduced 37.92%	454,660 $36.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	732,406	732,406 $51.8 Million

Others Institutions Holding GILD

# of Institutions

2,347

Shares Held

1.03B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $150B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Gilead Sciences, Inc. Transaction History